Skip to main content
. 2020 Jun 12;11:894. doi: 10.3389/fphar.2020.00894

Figure 2.

Figure 2

Schematic representation of the developed 1-compartment voriconazole PK model, with a scale-factor for plasma to saliva voriconazole distribution.